4.2 Letter

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Respiratory System

Pulmonary Fibrosis in the Time of COVID-19

Ivette Buendia-Roldan et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Review Respiratory System

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

Eusebi Chiner-Vives et al.

Summary: COVID-19, declared as a pandemic by the World Health Organization, has affected millions of people worldwide, especially those with underlying chronic illnesses. The virus can worsen pre-existing respiratory diseases and cause severe symptoms such as respiratory distress and pneumonia.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Letter Critical Care Medicine

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Laure Gallay et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Editorial Material Respiratory System

Interstitial lung disease before and after COVID-19: a double threat?

Claudia Valenzuela et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Immunology

Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis

Lichen Ouyang et al.

Summary: The prevalence of ILD in COVID-19 patients is relatively low, but those with ILD are more likely to experience severe illness and death. Compared to patients without ILD, COVID-19 patients with ILD have significantly higher mortality rates and ICU admission rates.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Respiratory System

Interstitial lung disease increases susceptibility to and severity of COVID-19

Hyun Lee et al.

Summary: The study found that patients with ILD have a significantly higher risk of contracting and developing severe COVID-19 compared to those without ILD. The risks of COVID-19 and severe presentation were significantly higher in patients with ILD.

EUROPEAN RESPIRATORY JOURNAL (2021)

Letter Rheumatology

COVID-19 pneumonia can cause irreversible lung damage in dermatomyositis with pre-existing interstitial lung disease

Satoshi Hama et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Critical Care Medicine

Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study

Anthony J. Esposito et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Critical Care Medicine

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease An International Multicenter Study

Thomas M. Drake et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Medicine, General & Internal

Spectrum of Fibrotic Lung Diseases

Marlies Wijsenbeek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis

Shirley Sze et al.

ECLINICALMEDICINE (2020)

Review Respiratory System

Fibrosing interstitial lung diseases: knowns and unknowns

Vincent Cottin et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)